These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases. Qasba PK Bioconjug Chem; 2015 Nov; 26(11):2170-5. PubMed ID: 26065635 [TBL] [Abstract][Full Text] [Related]
43. One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates. Shi W; Li W; Zhang J; Li T; Song Y; Zeng Y; Dong Q; Lin Z; Gong L; Fan S; Tang F; Huang W Acta Pharm Sin B; 2022 May; 12(5):2417-2428. PubMed ID: 35646546 [TBL] [Abstract][Full Text] [Related]
44. A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies. Ohata J; Ball ZT J Am Chem Soc; 2017 Sep; 139(36):12617-12622. PubMed ID: 28810739 [TBL] [Abstract][Full Text] [Related]
45. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor. Zou G; Ochiai H; Huang W; Yang Q; Li C; Wang LX J Am Chem Soc; 2011 Nov; 133(46):18975-91. PubMed ID: 22004528 [TBL] [Abstract][Full Text] [Related]
46. Chemoenzymatic Glycan Remodeling of Natural and Recombinant Glycoproteins. Yang Q; Wang LX Methods Enzymol; 2017; 597():265-281. PubMed ID: 28935106 [TBL] [Abstract][Full Text] [Related]
47. Liposome functionalization with copper-free "click chemistry". Oude Blenke E; Klaasse G; Merten H; Plückthun A; Mastrobattista E; Martin NI J Control Release; 2015 Mar; 202():14-20. PubMed ID: 25626085 [TBL] [Abstract][Full Text] [Related]
48. Current methods for the synthesis of homogeneous antibody-drug conjugates. Sochaj AM; Świderska KW; Otlewski J Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886 [TBL] [Abstract][Full Text] [Related]
49. Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody-Drug Conjugates. Matsuda Y; Seki T; Yamada K; Ooba Y; Takahashi K; Fujii T; Kawaguchi S; Narita T; Nakayama A; Kitahara Y; Mendelsohn BA; Okuzumi T Mol Pharm; 2021 Nov; 18(11):4058-4066. PubMed ID: 34579528 [TBL] [Abstract][Full Text] [Related]
51. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs. Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951 [TBL] [Abstract][Full Text] [Related]
52. Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes. Drake PM; Albers AE; Baker J; Banas S; Barfield RM; Bhat AS; de Hart GW; Garofalo AW; Holder P; Jones LC; Kudirka R; McFarland J; Zmolek W; Rabuka D Bioconjug Chem; 2014 Jul; 25(7):1331-41. PubMed ID: 24924618 [TBL] [Abstract][Full Text] [Related]
53. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. Acchione M; Kwon H; Jochheim CM; Atkins WM MAbs; 2012; 4(3):362-72. PubMed ID: 22531451 [TBL] [Abstract][Full Text] [Related]
54. First site-specific conjugation method for native goat IgG antibodies via glycan remodeling at the conserved Fc region. Dolan ME; Sadiki A; Wang LL; Wang Y; Barton C; Oppenheim SF; Zhou ZS Antib Ther; 2024 Jul; 7(3):233-248. PubMed ID: 39262442 [TBL] [Abstract][Full Text] [Related]
56. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates. Yamada K; Ito Y Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187 [TBL] [Abstract][Full Text] [Related]
57. Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases. Li C; Li T; Wang LX Methods Mol Biol; 2018; 1827():367-380. PubMed ID: 30196507 [TBL] [Abstract][Full Text] [Related]
58. Advances in the Development of Site-Specific Antibody-Drug Conjugation. Zhou Q; Kim J Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178 [TBL] [Abstract][Full Text] [Related]
60. Reliable and efficient procedures for the conjugation of biomolecules through Huisgen azide-alkyne cycloadditions. Lallana E; Riguera R; Fernandez-Megia E Angew Chem Int Ed Engl; 2011 Sep; 50(38):8794-804. PubMed ID: 21905176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]